Collegium to Participate in H.C. Wainwright Global Investment Conference

STOUGHTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that management will present at the H.C. Wainwright Global Investment Conference being held at the Fontainebleau Miami Beach Hotel from May 23-26, 2022.

Details of the event are as follows:Presentation Date and Time: Tuesday, May 24, 2022, at 3:30 pm ET

About Collegium Pharmaceutical, Inc.Collegium is a diversified, specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Contact:Alex DasallaHead of Investor Relations[email protected]

You May Also Be Interested In

• Crypto News Today: AlphaPepe Presale Nears Sell Out As Bitcoin Price Prediction Eyes $200,000
• Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Provides New Details on FF’s EAI Data Factory, Q3 “Four-Core Full-Stack AI” Robotics Practical Deployment Campaign and
• As the World Cup Unites the World Through One Common Goal, ELEKTROS Inc. Unites the World Through One Common Vision: Advancing Electric Vehicles, Electric Mobility, Cleaner Air, and a Better Future fo